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Immunoproteasome induction is suppressed in
hepatitis C virus-infected cells in a protein kinase
R-dependent manner
In Soo Oh1,2,10, Kathrin Textoris-Taube3,10, Pil Soo Sung1, Wonseok Kang1, Xenia Gorny4, Thilo Kähne5,
Seon-Hui Hong1, Young Joon Choi1, Clemens Cammann4, Michael Naumann5, Jong Hoon Kim1,
Su-Hyung Park6, Ook Joon Yoo7, Peter M Kloetzel3,8, Ulrike Seifert4,9 and Eui-Cheol Shin1
By changing the relative abundance of generated antigenic peptides through alterations in the proteolytic activity, interferon
(IFN)-γ-induced immunoproteasomes inﬂuence the outcome of CD8+ cytotoxic T lymphocyte responses. In the present study, we
investigated the effects of hepatitis C virus (HCV) infection on IFN-γ-induced immunoproteasome expression using a HCV
infection cell culture system. We found that, although IFN-γ induced the transcriptional expression of mRNAs encoding the
β1i/LMP2, β2i/MECL-1 and β5i/LMP7 immunoproteasome subunits, the formation of immunoproteasomes was signiﬁcantly
suppressed in HCV-infected cells. This ﬁnding indicated that immunoproteasome induction was impaired at the translational or
posttranslational level by HCV infection. Gene silencing studies showed that the suppression of immunoproteasome induction is
essentially dependent on protein kinase R (PKR). Indeed, the generation of a strictly immunoproteasome-dependent cytotoxic T
lymphocyte epitope was impaired in in vitro processing experiments using isolated 20S proteasomes from HCV-infected cells and
was restored by the silencing of PKR expression. In conclusion, our data point to a novel mechanism of immune regulation by
HCV that affects the antigen-processing machinery through the PKR-mediated suppression of immunoproteasome induction in
infected cells.
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INTRODUCTION
The clearance of viral infection is dependent on vigorous
CD8+ cytotoxic T lymphocyte (CTL) responses, which must
be tightly regulated to prevent immune-mediated host tissue
damage. Virus-infected cells are recognized and destroyed
by speciﬁc CTLs that bind to virus-derived peptide epitopes
associated with cell surface major histocompatibility
complex (MHC) class I molecules.1,2 Most of these antigenic
peptides, which are usually 8–10 amino-acid residues in
length, are generated by the 30S proteasome complex, which
is the central proteolytic machinery of the ubiquitin-
proteasome-system.3,4
The 30S complex is composed of the 20S proteasome
proteolytic core complex and two associated 19S regulatory
particles.4,5 The 20S complex is arranged as four staggered
rings, each containing seven non-identical subunits. The outer
rings contain the α subunits (α1–α7), which form the ‘gates’
through which substrates enter and products are released.5
Each of the two inner rings contains the β subunits (β1–β7),
three of which (β1, β2 and β5) harbor the six active sites.5
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Type I and II interferons (IFNs), which are major
cytokines in viral infection, induce the expression of the
immunosubunits (i-subunits) β1i/LMP2, β2i/MECL-1 and
β5i/LMP7 in non-immune cells and the assembly of the so
called immunoproteasomes (i-proteasomes).5,6 In addition,
i-proteasomes are constitutively expressed in hematopoietic/
immune cells, such as dendritic cells.7,8 Because of the
altered proteolytic activity, i-proteasomes have been shown
to exhibit altered frequencies in cleavage site usage. This
affects the relative abundance of the generated antigenic
peptides, which in turn can inﬂuence the quality of the
peptide-speciﬁc CD8+ CTL response.9 For example, the
generation of the hepatitis B virus (HBV) core 141–151
epitope has been shown to be strongly inﬂuenced by the
structural presence of the i-subunit β5i/LMP7.10 Addition-
ally, it has been shown that β1i/LMP2- or β5i/LMP7-
deﬁcient mice are unable to efﬁciently generate and present
some CD8+ CTL epitopes11–13 while the CD8+ CTL response
was barely affected in β1i/LMP2- or β5i/LMP7-deﬁcient
mice infected with lymphocytic choriomeningitis virus.14,15
Recent reports demonstrated that quantitative changes in
the epitope generation of i-subunit-deﬁcient mice result in
alterations of the immunodominance hierarchy and the
T-cell repertoire in a murine inﬂuenza infection model.16
Another study using mice completely lacking i-proteasomes
indicated that the peptide repertoire presented by dendritic
cells in the lymphoid organs differed from that presented by
wild-type dendritic cells by 50%.17 In addition to affecting
the outcome of the CTL response, i-proteasomes also
possess an important proteostatic function in preserving
cell viability under conditions of IFN-induced oxidative
stress.18,19 For example, in a murine model of coxsackievirus
infection, i-proteasomes were shown to protect mice against
oxidant protein damage in the injured myocardium.20
Hepatitis C virus (HCV) is one of the most common causes
of chronic liver disease. Although some patients successfully
clear the virus after acute HCV infection, most patients fail to
eliminate the virus and develop chronic persistent infection
accompanied by inﬂammatory liver injury.21 The outcome of
HCV infection is determined by virus-speciﬁc cellular immune
responses.22–25 Indeed, patients who control their HCV infec-
tion have broad CD8+ T-cell responses with higher functional
avidity, whereas CD8+ T-cell responses are impaired in patients
with persistent HCV infection.23–26
HCV evades host immune responses through various
mechanisms, leading to chronic persistent infection.27
However, little is known regarding the effects of HCV
infection on the epitope-processing machinery, which is
essential for the recognition of infected cells by CTLs. In the
present study, we investigated the i-proteasome induction in
HCV-infected cells. We demonstrate that i-proteasome
induction is suppressed and that protein kinase R (PKR) is
responsible for the suppression of i-proteasome induction in
HCV-infected cells.
MATERIALS AND METHODS
Cell culture
Huh-7.5, a human hepatoma cell line, was obtained from Apath
(Brooklyn, NY, USA) and maintained in Dulbecco’s modiﬁed Eagle’s
medium (Welgene, Daegu, Korea) containing 10% fetal bovine serum
(Welgene), 4.5 g l− 1 glucose, 1% penicillin/streptomycin (Invitrogen,
Carlsbad, CA, USA), and 4 mM L-glutamine in 5% CO2 at 37 °C.
HCV preparation, infection and IFN-γ treatment
The JFH-1 strain (genotype 2a) of HCV was produced by transfecting
Huh-7.5 cells with in vitro-transcribed RNA from a plasmid encoding
the full JFH-1 HCV genome (provided by Apath), as previously
described.28 After HCV RNA transfection, the cell culture supernatant
was used to infect naive Huh-7.5 cells. Subsequently, the cell culture
supernatant with the highest HCV RNA titer was taken and further
concentrated with WelProt virus concentration reagent (Welgene) to
prepare the HCV cell culture (HCVcc) stock.
For the HCV infection experiments, naive Huh-7.5 cells were
infected with HCVcc stock at a multiplicity of infection (MOI) of 0.01
in culture dishes. At 3 days after infection, the cells were subcultured
for IFN-γ treatment. Two days after being subcultured, the cells were
treated with 10 ng ml− 1 of IFN-γ for 24 or 48 h, and i-proteasome
induction was examined.
Immunoblot analysis
Cell lysates were prepared using RIPA buffer (Thermo Scientiﬁc,
Rockford, IL, USA) supplemented with protease inhibitors and
phosphatase inhibitors and were quantiﬁed by a bicinchoninic assay
(Pierce, Rockford, IL, USA). Then 10 μg of cell lysate was electro-
phoresed through a 10% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) gel and transferred onto a polyvinylidene
diﬂuoride membrane (Bio-Rad Laboratories, Richmond, CA, USA).
Speciﬁc proteins were detected using mouse anti-HCV core (Thermo
Scientiﬁc), rabbit anti-β1i (Abcam, Cambridge, MA, USA), goat anti-
β2i (Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse anti-β5i
(Santa Cruz Biotechnology), rabbit anti-α4, rabbit anti-β5 (Thermo
Scientiﬁc), mouse anti-tubulin (Sigma-Aldrich, St Louis, MO, USA),
rabbit anti-PKR (Santa Cruz Biotechnology), rabbit anti-phospho-
PKR (Cell Signaling, Beverly, MA, USA) or anti-IFNGR1 (Abcam)
antibodies. In addition, proteasome antibodies from a laboratory stock
were used. After overnight incubation with primary antibodies at 4 °C,
protein bands were visualized by horseradish peroxidase-conjugated
anti-mouse Ig (BD Biosciences, San Jose, CA, USA), anti-rabbit IgG
(Jackson ImmunoResearch Laboratories, West Grove, PA, USA) or
anti-goat IgG (Santa Cruz Biotechnology) antibodies and enhanced
chemiluminescence. The density of the resulting protein bands was
analyzed using the ImageJ densitometry software (National Institutes
of Health, Bethesda, MD, USA).
Flow cytometry
HCV-infected cells were ﬁxed and permeabilized using FoxP3 staining
buffer (eBioscience, San Diego, CA, USA). The intracellular HCV core
protein was stained with anti-HCV core IgG1 to detect HCV-infected
cells. After secondary staining with allophycocyanin-conjugated goat
anti-mouse Ig (BD Biosciences), the cells were analyzed using an LSR
II instrument (BD Biosciences) and the FlowJo software (TreeStar,
Ashland, OR, USA).
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Puriﬁcation of the 20S proteasome complex
Frozen cells were lysed in lysis buffer (20 mM Tris, pH 7.2, 1 mM
EDTA, 1 mM sodium azide, 1 mM dithiothreitol, 50 mM NaCl, 0.1%
NP-40) and homogenized. The lysates were centrifuged, the super-
natant was applied onto DEAE-Sephacel (GE Healthcare, Little
Chalfont, UK) and unbound proteins were removed by washing.
Proteasome complexes were eluted with 400 mM NaCl in TEAD buffer
(20 mM Tris, pH 7.2, 1 mM EDTA, 1 mM sodium azide, 1 mM
dithiothreitol, 400 mM NaCl) and were subsequently concentrated by
ammonium sulfate precipitation. Protein-containing fractions were
separated by ultracentrifugation (285 000 g for 16 h) using a SW40Ti
rotor (Beckman Coulter, Brea, CA, USA). Subsequently, fractions
containing proteasomes were pooled, applied to a Mono Q column
(GE Healthcare), and eluted with a gradient of 100–1000 mM NaCl in
TEAD. The purity of the eluted proteasomes was assessed by
Coomassie brilliant blue-stained SDS-PAGE.
Two-dimensional gel electrophoresis
To separate the subunits of the 20S proteasome complex, isoelectric
focusing by carrier ampholytes was combined with SDS-PAGE.
Proteasomes were applied to a carrier ampholyte isoelectric focusing
gel. In the second dimension, proteins were loaded onto SDS-PAGE
and stained with Coomassie brilliant blue G-250. Subsequently,
protein identiﬁcation was performed as described earlier.29 Liquid
chromatography–tandem mass spectrometric analysis was carried out
on a LTQ Orbitrap Velos Pro (Thermo Scientiﬁc, San Jose, CA, USA)
mass spectrometer, and raw data were processed toward protein
identiﬁcation utilizing PEAKS Studio V.7.0 (Bioinformatics Solutions,
Waterloo, Ontario, Canada).
Quantitative real-time PCR
Total RNA was extracted from cell pellets using a Ribospin Kit
(GeneAll Biotechnology, Seoul, Korea). Subsequently, cDNA was
synthesized using a High Capacity RNA-to-cDNA Kit (Applied
Biosystems, Foster City, CA, USA). TaqMan real-time PCR was
performed on a CFX96 real-time PCR detection machine (Bio-Rad
Laboratories) using a Kapa Probe Fast qPCR Kit (Kapa Biosystems,
Woburn, MA, USA) and TaqMan probes (Applied Biosystems). The
expression level of each gene was normalized to the mRNA levels of
β-actin, which was used as an endogenous control.
Short-hairpin RNA (shRNA) lentiviruses
A validated clone of the shRNA bacterial glycerol stock with lentiviral
constructs expressing PKR shRNA was obtained from Sigma-Aldrich.
The lentiviral vector was transfected into 293TN cells (System
Biosciences, Mountain View, CA, USA) with Lipofectamine 2000
transfection reagent (Invitrogen), and lentiviral particles were har-
vested from the transfected cells after 48 h. Huh-7.5 cells were
transduced with PKR shRNA lentiviruses, and stable cell lines were
established by 4 weeks of antibiotic selection using 2 μg ml− 1 of
puromycin (Sigma-Aldrich).
In vitro peptide digestion assays
Twenty micrograms of the HBV core 131–162, 32-mer polypeptide
and 3 μg of puriﬁed proteasome complexes were incubated in 300 μl
TEAD buffer at 37 °C for the indicated time (37 μl per time point).
The reaction was terminated by the addition of triﬂuoroacetic acid.
The digested products were separated by reversed-phase chromato-
graphy on a 1 mm RP column (Beta Basic-18, 100× 1 mm, 3 μm,
150 Å, Thermo Scientiﬁc). Peptides were detected online with
electrospray ionization–mass spectrometry (DECA XP MAX iontrap
instrument; Thermo Scientiﬁc). The kinetics of the identiﬁed peaks in
time-dependent processing experiments (signal intensity versus time
of digestion) was analyzed using the LCQuan software version 2.5
(Thermo Scientiﬁc).
Statistical analysis
The statistical signiﬁcance of the data was analyzed by Mann–Whitney
U-test or paired t-test using GraphPad Prism version 5.01 (GraphPad
Software, San Diego, CA, USA). A P-value of o0.05 was considered
statistically signiﬁcant.
RESULTS
Induction of i-proteasomes by IFN-γ is suppressed in
HCV-infected cells
To examine the effects of HCV infection on i-proteasome
induction, we used the in vitro JFH-1 HCVcc infection system,
which reﬂects the entire viral life cycle from entry to virion
release. HCV infection was conﬁrmed by the intracellular
staining of the core antigen (Figure 1a). Initially, Huh7.5 cells
were treated with IFN-γ to induce the formation of i-protea-
somes. IFN-γ increased the expression levels of the i-protea-
some subunits β1i/LMP2, β2i/MECL-1 and β5i/LMP7 in
non-infected cells but did not alter the standard proteasome
subunit β5 expression and abundance of the non-replaceable
subunit α4 (Figure 1b). In contrast, the IFN-γ-triggered
induction of the i-proteasome subunits was signiﬁcantly
suppressed in HCV-infected cells (Figure 1b). The protein
band densities were analyzed and are presented in Figure 1c.
This effect was clearly observed as early as 3 days after HCV
infection (Figure 1d).
The suppressive effects of HCV infection on IFN-γ-mediated
i-subunit induction were conﬁrmed using different HCV
infection rates. To produce HCV-infected cells with various
infection rates, we infected Huh-7.5 cells with HCVcc at
10-fold dilution steps (Figure 2a). Protein expression analysis
revealed that the induction of i-proteasome subunits was most
severely suppressed in cells infected with the highest MOI
(Figure 2b), whereas the suppressive effect of HCV on
i-subunit induction was abrogated in cells infected with lower
MOIs (Figure 2b). The protein band densities were analyzed
and are presented in Figure 2c.
I-subunit incorporation into proteasome complexes is
reduced in HCV-infected cells
To directly assess i-proteasome formation, we isolated
20S proteasomes from HCV-infected and IFN-γ-treated
Huh-7.5 cells and analyzed their subunit composition by
two-dimensional gel electrophoresis. As a control, 20S protea-
some complexes were separated from non-infected Huh-7.5
cells either treated or not treated with IFN-γ. As shown in
Figure 3, two-dimensional gel electrophoresis revealed the
presence of both β1i/LMP2 and β5i/LMP7 in the IFN-γ-treated
and non-infected cells, indicating that the i-subunits were
incorporated into the 20S proteasome complex. In contrast,
β1i/LMP2 and β5i/LMP7 could not be detected in the 20S
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proteasomes isolated from non-treated Huh-7.5 control cells
(Figure 3). Interestingly, in agreement with the protein
expression data shown in Figures 1 and 2, β1i/LMP2 and
β5i/LMP7 incorporation was clearly reduced in the 20S
proteasomes isolated from IFN-γ-treated, HCV-infected cells
(Figure 3). This indicates that the IFN-γ-induced i-proteasome
assembly was reduced in the HCV-infected cells.
The induction of i-subunit mRNA expression is not
suppressed in HCV-infected cells
To decipher the molecular mechanisms of interference with
IFN-γ-mediated i-subunit induction in HCV-infected cells, we
ﬁrst examined the expression of IFN-γR in HCV-infected cells
and found that IFNGR1 is well expressed in HCV-infected cells
(Figure 4a). We also examined phosphorylation of signal
transducer and activator of transcription factor 1 (STAT1)
after IFN-γ treatment and found that STAT1 phosphorylation
was not impaired in HCV-infected cells (Figure 4a). Conse-
quently, we next studied the i-subunit expression at the mRNA
level in non-infected and HCV-infected cells. Interestingly, the
IFN-γ-induced mRNA expression of the i-subunits β1i/LMP2,
β2i/MECL-1 and β5i/LMP7 did not differ between the unin-
fected cells and HCV-infected cells (Figure 4b). This suggests
that HCV infection regulates the IFN-γ-induced i-proteasome
Figure 1 IFN-γ-induced i-subunit expression is suppressed in HCV-infected cells. (a–c) Huh-7.5 cells were infected with HCVcc at 0.01
MOI and cultured for 5 days. The infection rate was determined by anti-HCV core staining and ﬂow cytometry (a).The infection rate was
approximately 80%. HCV-infected or uninfected cells were treated with 10 ng ml−1 IFN-γ for the indicated times. The total cell lysates
were analyzed by immunoblotting for i-subunits (β1i/LMP2, β2i/MECL-1 and β5i/LMP7), standard proteasome subunits (α4 and β5), the
HCV core and tubulin (b). The protein band densities from three independent experiments are presented as a bar graph (mean± s.e.m.; c).
*Po0.05. (d) Huh-7.5 cells were infected with HCVcc at 0.01 MOI, cultured for 1, 3 or 5 days and treated with 10 ng ml−1 IFN-γ for
24 h. The total cell lysates were analyzed by immunoblotting for i-subunits (β1i/LMP2 and β5i/LMP7), the HCV core and tubulin.
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expression at the translational or posttranslational level and not
at the transcriptional level.
The IFN-γ-mediated induction of i-proteasomes is impaired
by PKR in HCV-infected cells
In HCV-infected cells, the translation of antiviral
IFN-stimulated genes is suppressed by PKR phosphorylation
and subsequent eukaryotic initiation factor 2α (eIF2α)
phosphorylation.30 In addition, we recently reported that
IFN-induced MHC class I expression is attenuated in
HCV-infected cells by the same mechanism and that effector
functions of CD8+ T cells are ultimately decreased.31 We
therefore hypothesized that the suppressive effects of HCV on
i-proteasome induction were mediated by PKR. To test this
hypothesis, we established PKR-silenced cell lines and tested
whether PKR silencing had an effect on the IFN-γ-induced
i-proteasome expression in HCV-infected cells. We ﬁrst
conﬁrmed that phosphorylation of eIF2α is abrogated in
PKR-silenced cells (Supplementary Figure S1) and found that
HCV RNA titer was not strikingly affected by PKR silencing
(Supplementary Figure S2). Interestingly, in contrast to the
data obtained for the HCV-infected Huh-7.5 cells expressing
PKR, immunoblot analyses of HCV-infected and PKR-silenced
cell lysates demonstrated that IFN-γ-mediated i-subunit induc-
tion was not suppressed (Figure 5a). The protein band densities
from PKR-silenced cell lysates were analyzed and are presented
in Figure 5b. We next examined the subunit composition of
isolated 20S proteasome complexes. Two-dimensional gel
electrophoresis showed that PKR silencing reconstituted the
incorporation of β1i/LMP2 and β5i/LMP7 into 20S protea-
somes in IFN-γ-treated, HCV-infected cells (Figure 5c). These
data were corroborated by immunoblot analyses of the isolated
Figure 2 HCV infection suppresses i-subunit expression in a dose-dependent manner. Huh-7.5 cells were infected with HCVcc at 10-fold
dilution steps (MOIs from 10−2 to 10−5) and cultured for 5 days. (a) The infection rate was determined by anti-HCV core staining and
ﬂow cytometry. (b) Cells were treated with 10 ng ml−1 IFN-γ for 24 h. Total cell lysates were analyzed by immunoblotting for i-subunits
(β1i/LMP2, β2i/MECL-1 and β5i/LMP7), standard proteasome subunits (α4 and β5), the HCV core and tubulin. (c) The protein band
densities are presented as a bar graph.
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Figure 3 The subunit composition of isolated 20S proteasome complexes. Huh-7.5 cells were infected with HCVcc at 0.01 MOI and
cultured for 5 days. The HCV-infected or uninfected cells were treated with 10 ng ml−1 IFN-γ for 48 h, and the 20S proteasome
complexes were isolated from cell lysates. Puriﬁed 20S proteasomes were analyzed by two-dimensional gel electrophoresis and mass
spectrometry.
Figure 4 Effect of HCV infection on IFN-γ signaling and i-subunit mRNA. Huh-7.5 cells were infected with HCVcc at an MOI of 0.01 and
cultured for 5 days. (a) HCV-infected or uninfected cells were treated with 10 ng ml−1 IFN-γ for 30 mins, and the total cell lysates were
analyzed by immunoblotting for IFNGR1, STAT1, phosphorylated STAT1, the HCV core and tubulin. (b) HCV-infected or uninfected cells
were treated with 10 ng ml−1 IFN-γ for the indicated times, and the total RNA was then puriﬁed from the cells. After cDNA synthesis, the
mRNA levels of i-proteasome subunits were quantiﬁed by TaqMan real-time PCR. The data from ﬁve independent experiments are
presented as a bar graph (mean± s.e.m.).
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20S proteasomes for the i-subunits β1i/LMP2, β2i/MECL-1 and
β5i/LMP7 (Figure 5d). Our data thus show that PKR is
responsible for the suppression of IFN-γ-triggered i-protea-
some induction in HCV-infected cells.
Impaired induction of i-proteasomes affects peptide
processing in HCV-infected cells
To investigate the function of the different 20S proteasomes,
we performed in vitro processing experiments analyzing the
Figure 5 I-proteasome induction in PKR-silenced cells. PKR-silenced Huh-7.5 cell lines were established by transduction with shRNA
lentiviruses. Control cells (shControl) and PKR-silenced cells (shPKR) were infected with HCVcc at an MOI of 0.01 and cultured for
5 days. (a) Cells were treated with 10 ng ml−1 IFN-γ for the indicated times. Cell lysates were analyzed by immunoblotting for PKR,
phosphorylated PKR, i-subunits (β1i/LMP2, β2i/MECL-1 and β5i/LMP7), standard proteasome subunits (α4 and β5), the HCV core and
tubulin. (b) The protein band densities from PKR-silenced cell lysates are presented as a bar graph. (c and d) The cells were treated with
10 ng ml−1 IFN-γ for 48 h, and the 20S proteasome complexes were isolated from the cell lysates. Separated 20S proteasomes were
analyzed by two-dimensional gel electrophoresis and Coomassie blue staining. β1i/LMP2 and β5i/LMP7 are indicated in the insets to the
right (c). The isolated 20S proteasome complexes were analyzed by immunoblotting for i-subunits (β1i/LMP2, β2i/MECL-1 and β5i/LMP7)
and standard proteasome subunits (α4 and β5) (d).
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proteasomal capacity to generate an epitope peptide from a
polypeptide precursor by mass spectrometry. Because an
i-proteasome-dependent epitope has not yet been identiﬁed
in HCV proteins, we investigated the generation of the HBV
core 141–151 peptide, known to be strongly dependent on the
presence of the i-subunit β5i/LMP7, from the substrate peptide
HBV core 131–162.10 As control, we determined the abun-
dance of the i-proteasome-independent peptides HBV core
131–140 and HBV core 131–142 among the cleavage products.
The 20S proteasomes isolated from the IFN-γ-treated Huh-7.5
cells generated the HBV core 141–151 peptide, whereas those
from cells without IFN-γ treatment processed only low epitope
amounts (Figure 6a). Importantly, and as expected, the 20S
proteasomes from the IFN-γ-treated, HCV-infected cells
displayed a strongly diminished level of HBV core 141–151
epitope generation, which was comparable to that of non-
treated Huh-7.5 control cells. In striking contrast, the HBV
core 141–151 epitope was generated by 20S proteasomes
derived from IFN-γ-treated, HCV-infected cells when PKR
was silenced (Figure 6a). As shown in Figure 6b, the generation
of the i-proteasome-independent peptides HBV core 131–140
and HBV core 131–142 was not regulated by IFN-γ treatment
or HCV infection. Collectively, our data point to a decisive role
of PKR in the HCV-mediated reduction of IFN-γ-induced
i-proteasome expression. The data suggest that PKR inhi-
bits the generation of i-proteasome-dependent epitopes or
epitopes that are favorably generated by the i-proteasomes in
infected cells.
DISCUSSION
In the present study, we investigated the effects of HCV
infection on IFN-γ-induced i-proteasome expression using an
in vitro HCVcc infection system. We found that HCV infection
prevented the induction of the i-proteasome subunits
β1i/LMP2, β2i/MECL-1 and β5i/LMP7 at the protein level in
a PKR-dependent manner. Furthermore, we demonstrated
i-proteasome suppression by studying not only the subunit
composition but also the function of the 20S proteasome
complexes isolated from HCV-infected cells. Previously, we
showed that type I and III IFNs are produced from HCV-
infected cells32 and that i-proteasomes can be induced by type I
IFNs.33 In future research, it should be examined whether type
I IFN-induced i-proteasome expression is also impaired by the
PKR-dependent mechanism in HCV-infected cells.
To combat viral infections, the expression of i-proteasomes
triggered by type I or type II IFNs, the generation of a virus-
derived peptide repertoire and the subsequent induction of
viral antigen-speciﬁc CD8+ CTLs is of major importance. On
one hand, a vigorous CTL response is beneﬁcial because it
allows the infected cells to be destroyed. On the other hand, the
release of IFNs by activated lymphocytes results in the
induction of oxidative stress. In particular, newly synthesized
proteins are sensitive to oxygen radicals, and the exposure of
cellular proteins to such radicals leads to oxidative protein
damage, the accumulation of proteins and the destruction of
both infected and non-infected cells.18
Viral interference with the i-proteasome function has been
shown to occur either on the transcriptional level or through
the direct interaction of viral proteins with the i-subunits. In
Figure 6 Generation of an i-proteasome-dependent epitope by the
isolated 20S proteasomes. The cells were infected with HCVcc at
an MOI of 0.01 and were cultured for 5 days. HCV-infected or
uninfected cells were treated with 10 ng ml−1 IFN-γ for 48 h, and
20S proteasome complexes were isolated from cell lysates. Puriﬁed
20S proteasome complexes were subsequently incubated with the
precursor substrate HBV core 131–162 polypeptide for the
indicated time periods. In vitro digests were analyzed by HPLC and
mass spectrometry for the presence of the β5i/LMP7-dependent
HBV core 141–151 epitope (a) and the β5i/LMP7-independent
HBV core 131–140 and 131–142 peptides (b).
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both human and mouse cytomegalovirus-infected ﬁbroblasts,
the transcription and protein expression of the i-proteasome
subunits are inhibited, thus preventing their incorporation into
nascent proteasome complexes.34 This mechanism was sug-
gested to lead to changes in the CTL epitope repertoire during
the effector phase of the immune response against cytomega-
lovirus infection.34 Direct interference with the proteasome
complex has been reported for the HIV-1 Tat protein, which
interacts with six β subunits of the 20S proteasome, as well as
with the β2i/MECL-1 and β5i/LMP7 i-subunits.35 In addition,
HCV NS3 directly binds to β5i/LMP7.36 Both mechanisms
result in impaired proteasomal proteolytic activity.35,36
In the present study, IFN-γ-induced i-proteasomes were
examined as important players in the antigen processing
of cytoplasmic proteins. However, the expression of other
components of the antigen-processing machinery is also
increased by IFN-γ. These antigen-processing proteins
include proteasome activator 28, transporters associated
with antigen processing, and endoplasmic reticulum amino-
peptidases.5,6,37–39 Given that IFN-γ-induced i-proteasome
expression is suppressed by a PKR-mediated mechanism in
HCV-infected cells, the protein expression of other antigen-
processing machinery components might also be suppressed by
the same mechanism in HCV-infected cells. Indeed, we
conﬁrmed this hypothesis by showing that IFN-γ-induced
proteasome activator 28 expression was suppressed in
HCV-infected cells (data not shown).
PKR phosphorylation, which is induced by double-stranded
RNA, leads to eIF2α phosphorylation and ultimately suppresses
new protein translation. In HCV infection, this pathway was
shown to be responsible for the impaired expression of
antiviral IFN-stimulated gene proteins.30 This is considered
to be one of the major mechanisms of HCV immune evasion
and has been shown to be dependent on the presence of a
speciﬁc polymorphism within the HCV strains.40 We demon-
strated that this mechanism operates to suppress IFN-induced
MHC class I molecule expression31 and i-proteasome induction
in HCV-infected cells. This indicates that the PKR-eIF2α
pathway regulates not only antiviral innate immune responses
but also CD8+ CTL responses and non-immune functions,
such as the maintenance of protein homeostasis under condi-
tions of IFN-induced oxidative stress. This further suggests that
the pathway can be targeted for anti-HCV drug development.
Recently, it was shown that cyclophilin inhibitors reduce PKR
phosphorylation and restore IFN-stimulated gene protein
expression in HCV-infected cells.41 It is thus worthwhile to
investigate whether cyclophilin inhibitors restore i-proteasome
induction in HCV-infected cells.
In the present study, we could not study directly the function
of CD8+ CTLs speciﬁc to i-proteasome-dependent HCV
epitopes because i-proteasome-dependent epitopes have not
yet been identiﬁed in HCV proteins. Instead, we examined
the generation of the HBV core 141–151 peptide, a strictly
i-proteasome-dependent CTL epitope. Previously, it was
demonstrated that the generation of the HBV core 141–151
peptide determines the activity of the CTL response.10
Moreover, the generation of the HBV core 141–151 peptide
has been used as a functional evidence of the i-proteasome
induction.33
In summary, we have shown that i-proteasome induction,
assembly and function is suppressed in HCV-infected cells in a
PKR-dependent manner. We propose the existence of an
HCV immune-regulation mechanism that affects the antigen-
processing machinery and the processing of cytoplasmic viral
proteins.
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